<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03442738</url>
  </required_header>
  <id_info>
    <org_study_id>PV 5294</org_study_id>
    <nct_id>NCT03442738</nct_id>
  </id_info>
  <brief_title>A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)</brief_title>
  <acronym>Endocuff</acronym>
  <official_title>A Prospective Randomized Comparison of the Adenoma Detection Rate in Screening Colonoscopy With and Without a Disposable Cap (ENDOCUFF VISION®)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norgine</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of ENDOCUFF VISION® (caps with soft, about 1
      cm long lateral feet of rubber (&quot;Endocuff&quot;) to flatten the colon folds) on ADR in a real-life
      setting (general practices) and in a homogenous patient collective (screening colonoscopies
      only).

      It is a prospective randomized multi centric study, with participation of at least 10 study
      sites (private practice). The study is an inverstigator-initiated trial (IIT).

      Depending on the randomization (closed envelope), the patients are examined with the standard
      instruments without or with ENDOCUFF VISION®.

      Group 1: screening colonoscopy with standard colonoscopes with ENDOCUFF VISION® Group 2:
      screening colonoscopy with standard colonoscopes without cap
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colonoscopy is currently the best method for the detection of colon carcinomas and, as
      precursor, adenomas, since these can also be biopsied and removed. Therefore, the screening
      colonoscopy was introduced at the end of 2002 (covered by state insurance) from the age of
      55. The main quality parameter for outcome quality is the adenoma detection rate (ADR), which
      correlates with the rate of the carcinomas prevented. However, since even smaller polyps,
      especially if they are flat or sunken, may be relevant for colon cancer development, the aim
      of colonoscopy should be to be able to recognize and remove as many adenomas as possible.
      There is a need to optimize the efficiency of screening colonoscopy by increasing the rate of
      adenoma detection, as it is known from many studies that approximately 15-30% of adenomas can
      be missed- even though the adenoma rate in the German screening colonoscopy register
      continues to increase over the years and currently stands at 28%.

      Previous studies on the increase of the adenoma detection rate by endoscopy concerning newer
      endoscope technologies including conventional caps have been almost entirely negative.

      For about 2 years, a newer version of ENDOCUFF VISION® caps (caps with soft, about 1 cm long
      lateral feet of rubber (Endocuff) to flatten the colon folds) is available which has already
      been used in about 8,000 colonoscopies in Germany and another 10,000 colonoscopies in Europe;
      there are no studies on this version of Endocuff caps.

      The aim of this study is to evaluate the effect of ENDOCUFF VISION® in a real-life setting
      (general practices) and in a homogenous patient collective (screening colonoscopies only).

      It is a prospective randomized multi centric study, with participation of at least 10 study
      sites (private practice). The study is an inverstigator-initiated trial (IIT).

      A new technique for ADR improvement within colonoscopy can only be tested in a comparative
      study in two groups comparing the adenoma rate between the two groups. An independent gold
      standard does not exist in this sense, but the confirmation by the endoscopically taken
      histology serves as gold standard for the diagnosis adenoma. The alternative of double
      examinations (tandem colonoscopy) in each patient is in the setting of private practice not
      feasible.

      Depending on the randomization (closed envelope), the patients are examined with the standard
      instruments without or with ENDOCUFF VISION®.

      Group 1: screening colonoscopy with standard colonoscopes with ENDOCUFF VISION® Group 2:
      screening colonoscopy with standard colonoscopes without cap
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma Detection Rate (ADR) in the two study groups</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>Differences in ADR with or without the new disposable ENDOCUFF VISION® cap. Hypothesis: Endocuff Vision improves the adenoma detection rate (ADR) by about 25% compared to the comparison group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ADR (all adenoma/all patients)</measure>
    <time_frame>12 months</time_frame>
    <description>ADR (all adenoma/all patients)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by location</measure>
    <time_frame>12 months</time_frame>
    <description>differences in adenoma subgroups (between intestinal folds with good accessibility, between intestinal folds with poor accessibility, on top of intestinal fold, behind intestinal fold )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by size</measure>
    <time_frame>12 months</time_frame>
    <description>measured by comparison with size of snare or forceps</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by form</measure>
    <time_frame>12 months</time_frame>
    <description>stem-based, broad-based, flat adenoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by histology</measure>
    <time_frame>12 months</time_frame>
    <description>loiw grade intraepithelial neoplasia (LGIN), high grade intraepithelial neoplasia (HGIN), sessile serrated Adenoma (SSA), Carcinoma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by adjustability</measure>
    <time_frame>12 months</time_frame>
    <description>adjustability of adenoma by colonoscope on a score scale from 1(very good) - 6 (poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of adenoma subgroups by resection practice</measure>
    <time_frame>12 months</time_frame>
    <description>resection of adenoma by biopsy, polypectomy, resection by forceps, none</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intervention times</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>duration of Intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>procedure technique</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>technical aspects of polypectomy/biopsy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1382</enrollment>
  <condition>Adenoma Detection Rate</condition>
  <arm_group>
    <arm_group_label>Group I Endocuff group</arm_group_label>
    <description>Group I Endocuff cap use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II standard colonoscope</arm_group_label>
    <description>Group II standard colonoscope, no further device used</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endocuff group</intervention_name>
    <description>Endocuff Vision cap on Standard colonoscope</description>
    <arm_group_label>Group I Endocuff group</arm_group_label>
    <arm_group_label>Group II standard colonoscope</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Screening Population for Adenoma and CRC
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 55 years

          -  who voluntarily undergo a screening colonoscopy

          -  information and signed declaration of consent

        Exclusion Criteria:

          -  symptoms that may indicate a colonic disease

          -  rectal/colonic bleeding

          -  known colon disease for further diagnosis, e.g. Carcinoma, polyps for erosion,
             inflammatory bowel disease, stenosis

          -  follow-up/surveillance after colon carcinoma surgery or polypectomy

          -  anticoagulant drugs that make a biopsy or polypectomy impossible

          -  poor general condition (from ASA (American Society of Anesthesiologists
             Classification) III)

          -  partial/incomplete colonoscopy planned
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Rösch</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Rösch, Prof.</last_name>
    <phone>+49 40 7410</phone>
    <phone_ext>50098</phone_ext>
    <email>t.roesch@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tania Noder</last_name>
    <phone>+49 40 7410</phone>
    <phone_ext>50089</phone_ext>
    <email>t.noder@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gastroenterologische Spezialpraxis am Wittenbergplatz</name>
      <address>
        <city>Berlin</city>
        <zip>10318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gastroenterologische Spezialpraxis am Wittenbergplatz</last_name>
      <phone>+49 30 5293310</phone>
      <email>info@dr-mross.de</email>
    </contact>
    <investigator>
      <last_name>Michael Mroß, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Hohenzollerndamm</name>
      <address>
        <city>Berlin</city>
        <zip>10713</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gemeinschaftspraxis Hohenzollerndamm</last_name>
      <phone>+49 308647640</phone>
      <email>schroeder@schonack-schroeder.de</email>
    </contact>
    <contact_backup>
      <last_name>Gemeinschaftspraxis Hohenzollerndamm</last_name>
      <email>nehm@schonack-schroeder.de</email>
    </contact_backup>
    <investigator>
      <last_name>Andreas Schröder, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Klaus Nehm, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterologie am Bayerischen Platz</name>
      <address>
        <city>Berlin</city>
        <zip>10825</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gastroenterologie am Bayerischen Platz</last_name>
      <phone>+49 30 81459190</phone>
      <email>gastroenterologen@berlin.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Liceni, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Armerding, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefan Schubert, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Mayr</name>
      <address>
        <city>Berlin</city>
        <zip>12163</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Praxis Dr. Mayr</last_name>
      <phone>+49 30 7912041</phone>
      <email>info@praxis-mayr.de</email>
    </contact>
    <investigator>
      <last_name>Michael Mayr, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Heller, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Praxis für Gastroenterologie in Berlin Reinickendorf</name>
      <address>
        <city>Berlin</city>
        <zip>13437</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Praxis für Gastroenterologie in Berlin Reinickendorf</last_name>
      <phone>+49 30 40914570</phone>
      <email>praxis@aminalai.de</email>
    </contact>
    <investigator>
      <last_name>Alireza Aminalai, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. med. Jens Aschenbeck</name>
      <address>
        <city>Berlin</city>
        <zip>13581</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Praxis Dr. med. Jens Aschenbeck</last_name>
      <phone>+49 30 3314444</phone>
      <email>info@aschenbeck-berlin.de</email>
    </contact>
    <investigator>
      <last_name>Jens Aschenbeck, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastropraxis Eppendorfer Baum</name>
      <address>
        <city>Hamburg</city>
        <zip>20249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gastropraxis Eppendorfer Baum</last_name>
      <phone>+49 40+471103660</phone>
      <email>info@gastropraxis-eppendorferbaum.de</email>
    </contact>
    <investigator>
      <last_name>Michael Bläker, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beate Keck, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nina Hansen-Rosenblatt, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis CCB Bergedorf</name>
      <address>
        <city>Hamburg</city>
        <zip>21029</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Schwerpunktpraxis CCB Bergedorf</last_name>
      <phone>+49 40 72005020</phone>
      <email>info@sp-ccb.de</email>
    </contact>
    <investigator>
      <last_name>Wolfgang Burmeister, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katrin Niemax, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Magen-Darm-Zentrum, Facharztzentrum Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Magen-Darm-Zentrum, Facharztzentrum Eppendorf</last_name>
      <phone>+49 40 360 35 22</phone>
      <phone_ext>0</phone_ext>
      <email>prof.miehlke@mdz-hamburg.de</email>
    </contact>
    <investigator>
      <last_name>Stephan Miehlke, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667.</citation>
    <PMID>20463339</PMID>
  </reference>
  <reference>
    <citation>Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086.</citation>
    <PMID>24693890</PMID>
  </reference>
  <reference>
    <citation>Bretagne JF, Ponchon T. Do we need to embrace adenoma detection rate as the main quality control parameter during colonoscopy? Endoscopy. 2008 Jun;40(6):523-8. doi: 10.1055/s-2007-995786. Epub 2008 May 8.</citation>
    <PMID>18464196</PMID>
  </reference>
  <reference>
    <citation>van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. Review.</citation>
    <PMID>16454841</PMID>
  </reference>
  <reference>
    <citation>Brenner H, Altenhofen L, Kretschmann J, Rösch T, Pox C, Stock C, Hoffmeister M. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. Gastroenterology. 2015 Aug;149(2):356-66.e1. doi: 10.1053/j.gastro.2015.04.012. Epub 2015 Apr 22.</citation>
    <PMID>25911510</PMID>
  </reference>
  <reference>
    <citation>Moriyama T, Uraoka T, Esaki M, Matsumoto T. Advanced technology for the improvement of adenoma and polyp detection during colonoscopy. Dig Endosc. 2015 Apr;27 Suppl 1:40-4. doi: 10.1111/den.12428. Review.</citation>
    <PMID>25556542</PMID>
  </reference>
  <reference>
    <citation>Omata F, Ohde S, Deshpande GA, Kobayashi D, Masuda K, Fukui T. Image-enhanced, chromo, and cap-assisted colonoscopy for improving adenoma/neoplasia detection rate: a systematic review and meta-analysis. Scand J Gastroenterol. 2014 Feb;49(2):222-37. doi: 10.3109/00365521.2013.863964. Epub 2013 Dec 16. Review.</citation>
    <PMID>24328858</PMID>
  </reference>
  <reference>
    <citation>Nagorni A, Bjelakovic G, Petrovic B. Narrow band imaging versus conventional white light colonoscopy for the detection of colorectal polyps. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008361. doi: 10.1002/14651858.CD008361.pub2. Review.</citation>
    <PMID>22258983</PMID>
  </reference>
  <reference>
    <citation>Biecker E, Floer M, Heinecke A, Ströbel P, Böhme R, Schepke M, Meister T. Novel endocuff-assisted colonoscopy significantly increases the polyp detection rate: a randomized controlled trial. J Clin Gastroenterol. 2015 May-Jun;49(5):413-8. doi: 10.1097/MCG.0000000000000166.</citation>
    <PMID>24921209</PMID>
  </reference>
  <reference>
    <citation>Floer M, Biecker E, Fitzlaff R, Röming H, Ameis D, Heinecke A, Kunsch S, Ellenrieder V, Ströbel P, Schepke M, Meister T. Higher adenoma detection rates with endocuff-assisted colonoscopy - a randomized controlled multicenter trial. PLoS One. 2014 Dec 3;9(12):e114267. doi: 10.1371/journal.pone.0114267. eCollection 2014.</citation>
    <PMID>25470133</PMID>
  </reference>
  <reference>
    <citation>van Doorn SC, van der Vlugt M, Depla A, Wientjes CA, Mallant-Hent RC, Siersema PD, Tytgat K, Tuynman H, Kuiken SD, Houben G, Stokkers P, Moons L, Bossuyt P, Fockens P, Mundt MW, Dekker E. Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial. Gut. 2017 Mar;66(3):438-445. doi: 10.1136/gutjnl-2015-310097. Epub 2015 Dec 16.</citation>
    <PMID>26674360</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Scheel M, Schröder A, Yenerim T, Wiedenmann B, Gauger U, Roll S, Rösch T. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol. 2012 Feb;10(2):155-9. doi: 10.1016/j.cgh.2011.10.026. Epub 2011 Nov 2.</citation>
    <PMID>22056301</PMID>
  </reference>
  <reference>
    <citation>Adler A, Aschenbeck J, Yenerim T, Mayr M, Aminalai A, Drossel R, Schröder A, Scheel M, Wiedenmann B, Rösch T. Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology. 2009 Feb;136(2):410-6.e1; quiz 715. doi: 10.1053/j.gastro.2008.10.022. Epub 2008 Oct 15.</citation>
    <PMID>19014944</PMID>
  </reference>
  <reference>
    <citation>Adler A, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, Scheel M, Schröder A, Keining C, Stange G, Wiedenmann B, Gauger U, Altenhofen L, Rösch T. Data quality of the German screening colonoscopy registry. Endoscopy. 2013 Oct;45(10):813-8. doi: 10.1055/s-0033-1344583. Epub 2013 Sep 9.</citation>
    <PMID>24019130</PMID>
  </reference>
  <reference>
    <citation>Adler A, Pohl H, Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W, Khalifa AC, Setka E, Koch M, Wiedenmann B, Rösch T. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut. 2008 Jan;57(1):59-64. Epub 2007 Aug 6.</citation>
    <PMID>17681999</PMID>
  </reference>
  <reference>
    <citation>Adler A, Roll S, Marowski B, Drossel R, Rehs HU, Willich SN, Riese J, Wiedenmann B, Rösch T; Berlin Private-Practice Gastroenterology Working Group. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum. 2007 Oct;50(10):1628-38.</citation>
    <PMID>17694415</PMID>
  </reference>
  <reference>
    <citation>Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mroß M, Scheel M, Schröder A, Gerber K, Stange G, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut. 2013 Feb;62(2):236-41. doi: 10.1136/gutjnl-2011-300167. Epub 2012 Mar 22.</citation>
    <PMID>22442161</PMID>
  </reference>
  <reference>
    <citation>Aminalai A, Rösch T, Aschenbeck J, Mayr M, Drossel R, Schröder A, Scheel M, Treytnar D, Gauger U, Stange G, Simon F, Adler A. Live image processing does not increase adenoma detection rate during colonoscopy: a randomized comparison between FICE and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroenterol. 2010 Nov;105(11):2383-8. doi: 10.1038/ajg.2010.273. Epub 2010 Jul 13.</citation>
    <PMID>20628363</PMID>
  </reference>
  <reference>
    <citation>Schachschal G, Mayr M, Treszl A, Balzer K, Wegscheider K, Aschenbeck J, Aminalai A, Drossel R, Schröder A, Scheel M, Bothe CH, Bruhn JP, Burmeister W, Stange G, Bähr C, Kießlich R, Rösch T. Endoscopic versus histological characterisation of polyps during screening colonoscopy. Gut. 2014 Mar;63(3):458-65. doi: 10.1136/gutjnl-2013-304562. Epub 2013 Jun 28.</citation>
    <PMID>23812324</PMID>
  </reference>
  <reference>
    <citation>Schachschal G, Sehner S, Choschzick M, Aust D, Brandl L, Vieth M, Wegscheider K, Baretton GB, Kirchner T, Sauter G, Rösch T. Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis. 2016 Mar;31(3):675-83. doi: 10.1007/s00384-016-2523-8. Epub 2016 Feb 4.</citation>
    <PMID>26847619</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Thomas Rösch</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>ADR</keyword>
  <keyword>adenoma</keyword>
  <keyword>polyp</keyword>
  <keyword>colon</keyword>
  <keyword>screening</keyword>
  <keyword>colorectal carcinoma (CRC)</keyword>
  <keyword>cap</keyword>
  <keyword>endoscopy</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>private practice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

